Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine weather Ginkgo biloba standardized extract (24%
ginkoflavonoglicozides and 6% terpenes) is effective in treatment of cognitive and
concentration impairment